HbA1c patients

Total

N (%)

Chi-square

χ² (p-value)

<7% HbA1c

N (%)

>7% HbA1c

N (%)

GBI

<10% (MI)

4 (1.6%)

0 (0.0%)

4 (1.3%)

0.705 (0.703)

10% - 30% (MO)

64 (25.0%)

12 (28.6%)

76 (25.5%)

>30% (SE)

188 (73.4%)

30 (71.4%)

218 (73.2%)

CAL

1 - 2 mm(MI)

6 (2.3%)

0 (0.0%)

4 (1.3%)

0.975 (0.614)

3 - 4 mm(MO)

28 (10.9%)

4 (9.5%)

76 (25.5%)

>5 mm(SE)

222 (86.7%)

38 (90.5%)

218 (73.2%)

>5 MTDP

N

188 (73.4%)

24 (57.1%)

212 (71.1%)

2.194 (0.139)

P

68 (26.6%)

18 (42.9%)

86 (28.9%)

TFO

N

182 (71.1%)

34 (81.0%)

216 (72.5%)

0.937 (0.333)

P

74 (28.9%)

8 (19.0%)

82 (27.5%)

BC

N

220 (85.9%)

32 (76.2%)

252 (84.6%)

1.315 (0.518)

D

26 (10.2%)

8 (19.0%)

34 (11.4%)

F

10 (3.9%)

2 (4.8%)

12 (4.0%)

<20 RT

N

218 (85.2%)

30 (71.4%)

248 (83.2%)

2.158 (0.142)

P

38 (14.8%)

12 (28.6%)

50 (16.8%)

TM

N

132 (51.6%)

8 (19.0%)

140 (47.0%)

9.843 (0.02*)

MI

40 (15.6%)

10 (23.8%)

50 (16.8%)

MII

32 (12.5%)

14 (33.3%)

46 (15.4%)

MIII

52 (20.3%)

10 (23.8%)

62 (20.8%)

FI

N

132 (51.6%)

24 (57.1%)

156 (52.3%)

4.321 (0.364)

FI

52(20.3%)

4 (9.5%)

56 (18.8%)

FII

40 (15.6%)

4(9.5%)

44 (14.8%)

FIII

14 (5.5%)

2 (4.8%)

16 (5.4%)

FIV

18 (7.0%)

8 (19.0%)

26 (8.7%)